In today's interconnected world, infectious diseases pose an escalating threat, as demonstrated by the coronavirus pandemic ...

The FDA is expected to decide on treatments for COPD, psoriasis, rare neuroendocrine tumors, and a next-generation COVID-19 vaccine.

Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations of Paxlovid, currently the most prescribed oral treatment.

We want wide, fast, and affordable access for our new antiviral. It might sound counterintuitive, but a patent will help us ...

SEKISUI Diagnostics launches Metrix COVID/Flu Test for use at the point-of-care and home: Burlington, Massachusetts Thursday, April 3, 2025, 17:00 Hrs [IST] SEKISUI Diagnostics, a ...

COVID-19 has continued to alarm public health, and although several therapeutics and vaccines have been developed, the development of effective vaccines or antibodies is challenging due to mutations ...

Ensitrelvir PEP was safe and effective for COVID-19 prevention among household contacts when administered after the onset of symptoms in an index patient.

SEKISUI Diagnostics is a well-known provider of many rapid diagnostic solutions to the professional and home testing markets ...

FORT LAUDERDALE, FL / ACCESS Newswire / April 1, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a ...